Jacques Pantel

Jacques Pantel

Auto-generated profile, based on publicly available information

Jacques Pantel

Université Paris Cité, INSERM, CNRS, HealthFex Paris France

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AIAnorexia Nervosa Genetics Initiative
Anorexia Nervosa Genetics Initiative
HWHunna J. Watson
Hunna J. Watson
ECEating Disorders Working Group of the Psychiatric Genomics Consortium
Eating Disorders Working Group of the Psychiatric Genomics Consortium
ZYZeynep Yilmaz
Zeynep Yilmaz
LTLaura M. Thornton
Laura M. Thornton
CBCynthia Bulik
Cynthia Bulik

1 March 2006 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JPJacques Pantel
Jacques Pantel
MLMarie Legendre
Marie Legendre
SCSylvie Cabrol
Sylvie Cabrol
LHLatifa Hilal
Latifa Hilal
YHYassir Hajaji
Yassir Hajaji
SASerge Amselem
Serge Amselem
The growth hormone (GH) secretagogue receptor (GHSR) was cloned as the target of a family of synthetic molecules endowed with GH release properties. As shown recently through in vitro means, this receptor displays a constitutive activity whose clinical relevance is unknown. Although pharmacological studies have demonstrated that its endogenous ligand — ghrelin — stimulates, through the GHSR, GH secretion and appetite, the physiological importance of the GHSR-dependent pathways remains an open question that gives rise to much controversy. We report the identification of a GHSR missense mutation that segregates with short stature within 2 unrelated families. This mutation, which results in decreased cell-surface expression of the receptor, selectively impairs the constitutive activity of the GHSR, while preserving its ability to respond to ghrelin. This first description, to our knowledge, of a functionally significant GHSR mutation, which unveils the critical importance of the GHSR-associated constitutive activity, discloses an unusual pathogenic mechanism of growth failure in humans.

11 February 2014 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
VBV Boraska
V Boraska
CFC S Franklin
C S Franklin
JFJ A B Floyd
J A B Floyd
LTL M Thornton
L M Thornton
LHL M Huckins
L M Huckins
PWPamela Whittaker
Pamela Whittaker

1 November 2001 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KMKalotina Machinis
Kalotina Machinis
JPJacques Pantel
Jacques Pantel
INIrène Netchine
Irène Netchine
JLJuliane Léger
Juliane Léger
OCOlivier J.A. Camand
Olivier J.A. Camand
SASerge Amselem
Serge Amselem

1 June 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JPJacques Pantel
Jacques Pantel
KMKalotina Machinis
Kalotina Machinis
MSMARIE-LAURE SOBRIER
MARIE-LAURE SOBRIER
PDPhilippe Duquesnoy
Philippe Duquesnoy
MGMichel Goossens
Michel Goossens
SASerge Amselem
Serge Amselem
In humans, growth hormone receptor (GHR) transcripts exist in two isoforms differing by the retention (GHRfl) or exclusion (GHRd3) of exon 3, whereas in mice GHRfl is solely expressed. This species-specific expression pattern is believed to result from an alternative splice event that, on the basis of conflicting data obtained in humans, has been considered to be tissue-, developmentally, and/or individual-specific. To decipher the molecular basis of this unusual trait, we isolated a 6.8-kilobase fragment spanning exon 3 from individuals expressing GHRfl. Sequence analysis revealed the existence of two 99% identical retroelements flanking this exon. Unexpectedly, individuals expressing GHRd3 displayed a 2.7-kilobase deletion involving exon 3, which most likely results from an ancestral homologous recombination between the two retroelements. The lineage of these retroelements during primate evolution revealed the species specificity of the GHRd3 allele. These findings led us to propose a model underlying the existence of the sole GHRfl allele in most species. Such a retrovirus-mediated alternative splice mimicry, which clears up several as yet unexplained phenomena (i.e. the above-mentioned expression data, the Mendelian inheritance of GHR expression patterns, and the deletion of nonconsecutive exons in growth hormone resistant patients), represents a novel physiological mechanism accounting for protein diversity between and within species.

1 May 2005 in Endocrinology
Verified
Journal Article
Closed access
MLMarie-Christine Lacroix
Marie-Christine Lacroix
JGJean Guibourdenche
Jean Guibourdenche
Thierry FournierThierry Fournier
Thierry Fournier
ILIngrid Laurendeau
Ingrid Laurendeau
AIAhmed Igout
Ahmed Igout
DEDaniele Evain-Brion
Daniele Evain-Brion
A critical step in establishment of human pregnancy is the invasion of the uterus wall by the extravillous cytotrophoblast (EVCT), a process regulated by multiple autocrine and paracrine factors. Hormones belonging to the GH/prolactin family are expressed at the maternofetal interface. Because they are involved in cell motility in various models, we examined the possible regulatory role of human placental GH (hPGH) in EVCT invasiveness. By using an in vitro invasion model, we found that EVCT isolated from first-trimester chorionic villi and cultured on Matrigel secreted hPGH and expressed human GH receptor (hGHR). These data were confirmed by in situ immunohistochemistry. EVCT expressed the full-length and truncated forms of hGHR, and the Janus kinase-2/signal transducer and activator of transcription factor-5 signaling pathway was activated in EVCT by hPGH treatment. Strong hPGH and hGHR expression was observed when EVCT invaded Matrigel and moved through the pores of the filter on which they were cultured. hPGH stimulated EVCT invasiveness, and this effect was inhibited by a Janus kinase-2 inhibitor. Interestingly, hPGH was more efficient than pituitary GH in stimulating EVCT invasiveness. These results offer the first evidence for a placental role of hPGH and suggest an autocrine/paracrine role of hPGH in the regulation of trophoblast invasion.